Improving TCR Gene Therapy for Treatment of Haematological Malignancies

Adoptive immunotherapy using TCR gene modified T cells may allow separation of beneficial Graft versus tumour responses from harmful GvHD. Improvements to this include methods to generate high avidity or high affinity TCR, improvements in vector design and reduction in mispairing. Following adoptive...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicholson, Emma, Ghorashian, Sara, Stauss, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272793/
https://www.ncbi.nlm.nih.gov/pubmed/22319532
http://dx.doi.org/10.1155/2012/404081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272793/
https://www.ncbi.nlm.nih.gov/pubmed/22319532
http://dx.doi.org/10.1155/2012/404081

Ejemplares similares